Cell therapy/device combo for diabetes treatment is in the works

01/10/2013 | MedCityNews.com

Sernova is working on a polymer "cell pouch" system infused with therapeutic islet cells that can administer insulin based on a diabetes patient's blood glucose levels. The device, implanted below the skin in the abdomen using a 15-minute procedure, also will contain the Sertolin local immune protection cell system to prevent transplant rejection.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ